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need for surgery in patients with Crohn’s disease (CD). 
METHODS: Data of 506 patients with incident CD 
were analyzed (age at diagnosis: 31.5 ± 13.8 years). 
Both hospital and outpatient records were collected 
prospectively with a complete clinical follow-up and 
comprehensively reviewed in the population-based 
Veszprem province database, which includes incident 
CD patients diagnosed between January 1, 1977 and 
December 31, 2008. Follow-up data were collected until 
December 31, 2009. All patients included had at least 1 
year of follow-up available. Patients with indeterminate 
colitis at diagnosis were excluded from the analysis.
RESULTS: Overall, 73 patients (14.4%) required re-
sective surgery within 1 year of diagnosis. Steroid ex-
posure and need for biological therapy were lower in 
patients with early limited surgery (P  < 0.001 and P  
= 0.09). In addition, surgery rates during follow-up in 
patients with and without early surgery differed signifi-
cantly after matching on propensity scores (P  < 0.001, 
HR = 0.23). The need for reoperation was also lower in 
patients with early limited resective surgery (P  = 0.038, 
HR = 0.42) in a Kaplan-Meier and multivariate Cox re-
gression (P  = 0.04) analysis. However, this advantage 
was not observed after matching on propensity scores 
(P Logrank = 0.656, P Breslow = 0.498).
CONCLUSION: Long-term surgery rates and overall 
exposure to steroids and biological agents were lower 
in patients with early limited resective surgery, but re-
operation rates did not differ.
© 2013 Baishideng Publishing Group Co., Limited. All rights 
reserved.
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Core tip: An alternative approach may be early limited 
change in patient management; namely, increased and 
earlier use of  immunosuppressants and the introduc-
tion of  biological therapies. The effect of  azathioprine 
(AZA) on disease prognosis was until recently contro-
versial. Two recent population-based reports confirmed 
that early AZA use is associated with reduced need for 
surgery according to a Cox regression analysis and pro-
pensity score matching in two population-based cohorts 
from Wales and Hungary[5,6]. Furthermore, in a study 
from France, an association was reported between the 
duration of  anti-tumor necrosis factor (TNF) and AZA 
therapy and risk for surgery[7]. In contrast, in a previous 
referral center study from France, the need for intestinal 
surgery did not decrease despite the increased use of  im-
munosuppressants[8]. Of  note, in this study, AZA therapy 
was started only after surgery in the majority of  patients. 
Earlier AZA use is only one of  the complex changes in 
patient management. Other changes have also occurred, 
including a trend toward tight patient monitoring. More-
over, whether the risk of  surgery is affected by the more 
widespread use of  biological agents has yet to be demon-
strated by population-based studies.
An alternative approach to the predominant strategy 
of  initially using conservative therapy: using limited resec-
tive surgery in a selected group of  patients as a primary 
therapeutic option, may prove advantageous. In a study 
by Aratari et al[9], early surgery at diagnosis in 207 CD 
patients with ileocecal disease was associated with a more 
benign postoperative disease course, in comparison to 
patients receiving delayed surgery. Nevertheless, reopera-
tion rates were not reduced. Thus, in a subgroup of  CD 
patients, early surgery may represent a valid alternative to 
medical therapy; particularly in patients with limited, iso-
lated, stenotic ileocecal disease.
Therefore, our aim was to analyze the disease course, 
drug exposure and need for surgery and reoperation in 
patients with and without early (within 1 year of  diagno-
sis) limited resective surgery in a population-based cohort 
from Eastern Europe with a complete clinical follow-up.
MATERIALS AND METHODS
Patients
A well-characterized Hungarian cohort of  506 patients 
with incident CD (male/female: 251/255; age at diag-
nosis: 31.5 ± 13.8 years) diagnosed between January 1, 
1977 and December 31, 2008 were included. Follow-up 
data were collected until December 31, 2009. All patients 
included had at least 1 year follow-up available. Patients 
with indeterminate colitis at diagnosis were excluded 
from the analysis. The clinical data of  CD patients are 
summarized in Table 1. 
Methods
Clinical data were collected every year from the seven gen-
eral hospitals (departments of  internal medicine, surgery, 
and pediatrics) and gastroenterology outpatient units. The 
majority of  patients [76% of  ulcerative colitis (UC) and 
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resective surgery in a well-selected group of patients 
with Crohn’s disease. In this population-based study, 
we found that overall exposure to steroids and bio-
logical agents was lower in patients with early limited 
resective surgery; observed surgery rates were also 
lower, yet reoperation rates did not differ in the two 
groups after matching on propensity scores.
Golovics PA, Lakatos L, Nagy A, Pandur T, Szita I, Balogh M, 
Molnar C, Komaromi E, Lovasz BD, Mandel M, Veres G, Kiss 
LS, Vegh Z, Lakatos PL. Is early limited surgery associated 
with a more benign disease course in Crohn’s disease? World J 
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INTRODUCTION
Crohn’s disease (CD) has a variable course, but the ma-
jority of  patients eventually develop penetrating or stric-
turing complications. In addition, several environmental 
risk factors (diet, smoking, measles, or appendectomy) 
may contribute to its etiology and course. A significant 
adverse outcome is the need for surgery. Nevertheless, 
surgery is not curative in CD. Surgical resection is typi-
cally performed for emergency indications (e.g., obstruc-
tive symptoms and hemorrhage) or for failure to respond 
to medical therapy. 
Some years ago, a review article reported that the 
probability of  first resective surgery ranged from 38% 
to 96% in the first 15 years after diagnosis[1]. The overall 
clinical relapse and reoperation rates after initial resective 
surgery are 50%-60% and 28%-45%, respectively, during 
the following 15 years. Surgical resection rates over time 
vary widely among published studies, ranging between 25 
and 61% in the first 5 years. Until recently, there was little 
evidence that disease outcomes for CD had changed over 
recent decades. Recently, Peyrin-Biroulet et al[2] published 
a systematic review of  the natural history of  CD in pop-
ulation-based cohorts. According to the authors’ conclu-
sions, the impact of  changing treatment paradigms with 
the increased use of  immunosuppressants and biological 
agents on the natural history of  the disease was poorly 
understood. Available data did not suggest a significant 
change in outcome of  CD, with approximately half  of  
patients requiring surgery within 10 years of  diagnosis. 
The risk of  postoperative clinical recurrence within 10 
years was 44%-55%.
A recent meta-analysis from International Organiza-
tion for the Study of  Inflammatory Bowel Diseases (IOIBD) 
Epidemiology Task Force reported that the risk of  
surgery in CD in prebiologic population-based cohorts 
has been decreasing during the past decade[3]. One of  
the most striking changes was reported by Jess et al[4] in 
a Danish study. The rate of  early surgery (within 1 year 
of  diagnosis) has fallen from 35% (1962-1987) to 12% 
(2003-2004). During this time, there was a significant 
94% of  CD patients] were monitored at the Csolnoky 
F. Province Hospital in Veszprem, where data were also 
registered. Disease behavior was updated yearly. A more 
detailed description of  the data collection method, case as-
sessment, the geographical and socioeconomic background 
of  the province, and the results of  surgical and medical 
management, as well as a detailed description of  the Vesz-
prem Province inflammatory bowel disease (IBD) Group, 
was published in previous epidemiological studies[10-12].
The disease phenotype (age at onset, duration, loca-
tion, and behavior) was determined according to the 
Montreal Classification[13]. The presence of  perianal 
disease and behavior change during follow-up were also 
registered. Medical therapy was recorded in detail (as de-
fined by the European Crohn’s and Colitis Organisation 
Consensus Report[14]). The need for surgery or reopera-
tion and smoking habits were investigated by review of  
medical files and by questionnaire.
The study was approved by the Semmelweis Univer-
sity Regional and Institutional Committee of  Science and 
Research Ethics and by the Csolnoky F. Province Hospital 
Institutional Committee of  Science and Research Ethics.
Treatment policy
The majority of  the patients received maintenance thera-
py with sulfasalazine or a 5-aminosalicylic acid derivative 
(mesalazine or olsalazine), if  tolerated, especially until 
the mid-1990s. AZA or 6-mercaptopurine (6-MP) was 
used in selected cases as maintenance therapy for steroid-
dependent and -refractory patients or for patients with 
fistulizing disease. AZA and 6-MP were typically used 
following resective surgery until the late 1980s, and later 
on a more widespread basis beginning in the mid-1990s. 
Short-term oral corticosteroid treatment was used for 
clinical exacerbations, usually prednisone 40-60 mg/d, 
tapered and discontinued over the course of  2-3 mo. 
Beginning in the mid-1990s, methotrexate was used as 
second-line immunosuppressive therapy in limited cases. 
Since the late 1990s, infliximab has been used for both 
induction and maintenance therapy in selected cases. 
Surgical resection was performed for emergency in-
dications (e.g., obstructive symptoms and hemorrhage) 
and for failure to respond to medical therapy. Surgical 
techniques have also changed during the follow-up pe-
riod of  this study; laparoscopic surgery became available 
and more widely used from the late 1990s. Limited resec-
tions were more widely used from the mid-1990s than in 
the past, and there is very limited use of  defunctioning 
ileostomy (n = 4) formation in routine management of  
CD. For the majority of  patients in the present study, 
one of  the most experienced IBD surgeons in Hungary 
performed the operations, while laparoscopic surgery 
and stricturoplasty were performed only in a minority of  
cases. The definition of  early limited surgery was resec-
tion of  the terminal ileum or ileocecum within 1 year of  
diagnosis. 
Due to Hungarian health authority regulations, a fol-
low-up visit is obligatory for IBD patients at a specialized 
gastroenterology center every 6 mo. Otherwise, under the 
regulations of  the Hungarian National Health Insurance 
(OEP) system, the right to subsidized therapy is forfeited. 
Consequently, the relationship between IBD patients and 
specialists is a close one. 
Propensity score model
The authors used two propensity score models to control 
further for possible confounders, to quantify the prob-
ability of  surgery and reoperation in patients who had 
early limited resective surgery versus those who did not.
In the first propensity model, covariates included in 
the propensity score were selected according to a two-
step process. We first constructed an outcome model 
identifying independent predictors of  early limited resec-
tive surgery. Subsequently, we included in the model ad-
ditional predictors known to be associated with surgical 
outcome (e.g., age at onset and smoking) irrespective of  P 
value. We used multivariate logistic regression to estimate 
propensity scores of  early limited resection for each in-
dividual. Goodness-of-fit was evaluated by the Hosmer-
Lemeshow test, the P values of  which were not signifi-
cant. Using the predicted propensity scores from our 
model, we attempted to match all early limited surgery 
to identical CD patients without early limited surgery by 
5-to-1 greedy matching[15]. Additional analysis in patients 
with ileum-only disease was also performed. 
In the second propensity model, we aimed to analyze 
the probability of  reoperation in patients with and with-
out early surgery in a group of  CD patients with a his-
tory of  at least one resective operation. Using the above 
two-step process and predicted propensity scores from 
our model, we attempted to match all early surgery CD 
patients to identical CD patients with a non-early surgical 
resection through 5-to-1 greedy matching[15].
Ethical permission
The study protocol was approved by Semmelweis Univer-
sity Regional and Institutional Committee of  Science and 
Research Ethics and the Csolnoky F. Province Hospital 
Institutional Committee of  Science and Research Ethics
Statistical analysis
Variables were tested for normality by the Shapiro-Wilk 
W test. Wilcoxon rank sum test, χ 2 test, and χ 2 test with 
Yates correction and logistic regression were used to test 
differences in disease phenotype between subgroups of  
UC and CD patients for dichotomous variables. Kaplan-
Meier survival curves were plotted for analysis with 
log rank and Breslow tests to determine probability of  
surgical resection. Additionally, Cox regression analysis 
using the enter method was used to assess the associa-
tion between categorical clinical variables and time to 
AZA use and surgical requirements. Variables with P < 
0.2 in univariate analysis were included in the multivari-
ate testing. To control further for possible confounders, 
we developed a propensity score models (see below) for 
quantifying the probability of  reoperation in patients with 
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= 93), right hemicolectomy (n = 59), segmental colonic 
resection (n = 19), and subtotal colectomy/left hemico-
lectomy (n = 11 and 8, respectively). 
A further 36 (7.1%) patients had other surgical proce-
dures (abscess drainage or fistulectomy). Forty-two (8.4%) 
patients had two resective operations and 17 (3.4%) had 
three or more operations for CD during follow-up. Ileo-
cecal resection was the most common procedure overall.
The probability of  first intestinal surgery due to non-
malignant disease after 1, 5 and 10 years was 14.6%, 
30.1%, and 51.6%, respectively, in a Kaplan-Meier analy-
sis. The cumulative probability of  resective surgery rate 
decreased in patients diagnosed in the last decade [Group 
1 (1977-1998), Group 2 (1999-2008); PLogrank = 0.022, and 
PBreslow = 0.07]. 
Overall, 73 patients (14.4%) required resective surgery 
within 1 year of  diagnosis. Ten patients were excluded 
from further analysis from the early surgery group in 
whom extensive index surgery was performed. The 
prevalence of  early limited resective surgery did not dif-
fer significantly in the three cohorts [Cohort A (diagnosed 
1977-1989): 11.3%; Cohort B (1990-1998): 12.8%; and 
Cohort C (1999-2008): 13.4%]. Predictors of  early limited 
resective surgery were ileal location (P < 0.001), colonic 
location (P < 0.001), complicated behavior at diagnosis (P 
< 0.001), and age of  onset (P = 0.06, Table 2).
Overall steroid exposure was significantly lower (P 
= 0.001) in patients with early limited resection despite 
similar follow-up (median: 12 years). The same trend was 
observed for steroid dependency (P = 0.07) and overall 
biological agent exposure (P = 0.09). In contrast, overall 
AZA exposure was similar between the two groups. Of  
note, AZA exposure before surgery was 0% vs 28.8% (P 
< 0.001), while TNF-antagonist exposure before surgery 
was 0% vs 4.9% (P = 0.05) in patients with and without 
early limited surgery. In logistic regression analysis, dis-
ease location (P < 0.001) and disease behavior (P < 0.001) 
were associated with the need for early resective surgery 
(Table 3).
and without early limited resective surgery[15]. Matching 
on propensity scores is one technique commonly used to 
control for measured confounders in observational stud-
ies. P < 0.05 was considered significant. Results for con-
tinuous variables were expressed as median (lower and 
upper quartile) unless otherwise stated. For the statistical 




Five hundred and six residents in Veszprem Province 
were diagnosed with CD in the 32-year period. Follow-
up information was collected up to December 31, 2009, 
equaling 5758 patient-years of  follow-up. The clinical 
characteristics and disease course according to the year 
of  diagnosis is shown in Table 1. There were significant 
differences in disease phenotype, drug exposure, and 
smoking habits in the patient groups diagnosed in the 
early period and thereafter. Overall, exposure to AZA, 
systemic steroids and biological agents (after 1998 only) 
was 45.8%, 68.6% and 9.5%, respectively. Total AZA 
exposure increased in the subsequent cohorts despite 
shorter follow-up. 
Prevalence, predictors of surgery and early limited 
surgery and drug exposure
A total of  204 (40.7%) patients had at least one resective 
operation (5 patients with resective surgery due to ma-
lignant disease were excluded from analysis). The most 
common surgical procedures were ileocecal resection (n 
Table 1  Clinical characteristics of patients with Crohn’s 
disease
Characteristics n  = 506
Male/female 251/255
Age at presentation (yr)   31.5 ± 13.8 
Median follow-up (yr) 11.4 ± 7.8
Familial IBD 12.9%
Location (n)
   L1 166
   L2 182
   L3 155
   L4 only     3
Behavior (n) 
   B1 288
   At diagnosis B2 100
   B3 118
Perianal disease 25.5%
Total steroid exposure/dependent-refractory 68.6%/11.2%
Total azathioprine exposure 45.8%
Total biological exposure   9.1%
Smoking habits (n)
   No 224
   At diagnosis Ex   38
   Yes 244
L1: Ileal; L2: Colonic; L3: Ileocolonic; L4: Upper Gastrointestinal; B1: Inflam-
matory; B2: Stenosing; B3: Penetrating. IBD: Inflammatory bowel disease.
Table 2  Predictors of early limited surgery and drug 
exposures
Early surgery No early 
surgery
P  value OR (95%CI)
Age at onset (A1) 28.4% 19.0%    0.060 1.69 (0.97-2.96)
Ileal location 59.5% 28.1% < 0.001




85.1% 35.9% < 0.001 10.2 (5.2-20.1)
Overall steroid 
exposure
52.7% 71.3%    0.001 0.45 (0.27-0.74)
Steroid-dependent 
course
  2.6% 12.3%    0.070 0.19 (0.03-1.40
Overall biological 
exposure
  4.1% 10.0%    0.090 0.38 (0.12-1.26)
Overall azathioprine 
exposure
45.9% 45.8% > 0.050
Golovics PA et al . Early surgery in Crohn's disease
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Risk of operation in patients with and without early 
limited surgery
In a propensity score model, we compared surgery rates 
between patients with and without early resective surgery. 
In the early limited surgery model, propensity scores 
ranged from 0.02 to 0.56 (median: 0.29) in patients with 
early limited resection (n = 63), and from 0.02-0.55 (me-
dian: 0.14) in patients without early limited surgery (n 
= 428). Goodness-of-fit was evaluated by the Hosmer-
Lemeshow test, and P values were non-significant (P = 
0.653). 
Using a 5-to-1 greedy matching algorithm, we were 
able to match 58 patients from the early resective surgery 
group to patients with comparable phenotype without 
early limited resections (Table 4). The observed first resec-
tive surgery rate was 12.1%, 33.2%, and 53.6% after 2, 5 
and 10 years of  disease duration, respectively, in the lat-
ter group. In contrast, the reoperation rate in the former 
group was 1.8%, 5.8%, and 17.9% after 2, 5 and 10 years 
(PLogrank < 0.001, HR = 0.23, 95%CI: 0.11-0.48; Figure 1A).
If  the analysis was restricted to patients with ileum-
only location (n = 38), the observed first resective surgery 
rate was 21%, 35.3%, and 59.4% in patients without 
early surgery after 2, 5 and 10 years of  disease duration, 
respectively. In contrast, the observed reoperation rate in 
the other group was 0%, 5.8%, and 20.8% after 2, 5 and 
Table 3  Factors associated with the need for early limited 
surgery in logistic regression analysis
P  value OR 95%CI
Age at diagnosis
   A1    0.172 1.62 0.81-3.25
   A2 Reference
Disease location < 0.001
   L1 < 0.001 7.88 2.92-21.3
   L3    0.035 3.21 1.09-9.48
   L2 Reference
Disease behavior at diagnosis < 0.001
   B2 < 0.001 4.91 2.15-11.2
   B3 < 0.001 7.66 3.52-16.7
   B1 Reference
Smoking
   Yes    0.487 1.24 0.68-2.27
   No Reference
L1: Ileal; L2: Colonic; L3: Ileocolonic; B1: Inflammatory; B2: Stenosing; B3: 
Penetrating.
Table 4  Characteristics of patients with and without early 
resective surgery after matching on propensity scores
CD patient with 
early surgery 
(n  = 58)
CD patient without 
early surgery 
(n  = 58)1
Gender (male/female) 32/26 34/24
Age at onset below 40 yr 12 11
Decade of diagnosis
   1977-1989   8   9
   1990-1999 22 23
   2000-2008 28 26
Disease location
   L1 38 39
   L32 20 19
Disease behavior at diagnosis
   B1 10 10
   B2 20 19
   B3 28 29
Smoking (yes/no) 36/22 35/23
1Early resective surgery: within the year of diagnosis; 2Ileocecal. CD: 
Crohn’s disease; L1: Ileal; L2: Colonic; L3: Ileocolonic; B1: Inflammatory; 
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Figure 1  Need for surgery in Crohn's disease patients with and without 
an early limited surgery after matching on propensity scores. A: All Crohn's 
disease (CD) patients (n = 58), PLogrank < 0.001, HR = 0.23, 95%CI: 0.11-0.48; B: 
CD patients with ileal only disease location (n = 38). PLogrank < 0.001, HR = 0.25, 
95%CI: 0.11-0.58.
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10 years (PLogrank < 0.001, HR = 0.25, 95%CI: 0.11-0.58) 
(Figure 1B).
Reoperation rates and predictors for reoperation
The need for reoperation in patients with early limited 
resection at 5 years was 7.5%, at 10 years it was 16.5%, 
while for those without early resective surgery at 5 years 
it was 12.9%, and 36.3% at 10 years in a Kaplan-Meier 
analysis (PLogrank = 0.038, Figure 2). In a Cox regression 
analysis, early limited surgery (P = 0.04) was the only fac-
tor independently associated with the need for reopera-
tion (Table 5). 
Reoperation rates after matching on propensity scores
In addition, we developed a propensity score model to 
assess further the need for reoperation in patients with 
and without early resective surgery. After identifying pre-
dictors, multivariate logistic regression was used to esti-
mate propensity scores of  early limited resection for each 
individual. Goodness-of-fit was evaluated by the Hosmer-
Lemeshow test and P values were non-significant (P = 
0.812). In the early limited surgery model, propensity 
scores ranged from 0.10 to 0.83 (median: 0.45) in patients 
with early limited resection (n = 63), and from 0.02 to 
0.69 (median: 0.30) in patients with non-early surgery (n 
= 126). Using a 5-to-1 greedy matching algorithm, we 
were able to match 54 out of  63 (85.7%) patients with 
early limited surgery to patients with non-early surgery. 
As expected, the prevalence of  factors included in the 
propensity score model was well balanced across surgical 
groups (data not shown). 
The observed reoperation rates did not differ between 
the two groups (early surgery: 1.9%, 5.9%, and 17.7%; vs 
non-early surgery: 2%, 6.7%, and 25.1%, after 1, 5 and 10 
years, respectively, PLogrank > 0.05, Figure 3A). Similar re-
sults were found if  the analysis was restricted to patients 
with disease limited to the ileum only (n = 33, early sur-
gery: 0%, 5.8%, and 20%, vs non-early surgery: 0%, 7.7%, 
and 14.3%, after 1, 5 and 10 years, respectively, PLogrank > 
0.05, Figure 3B).
DISCUSSION
In the present study, we studied the benefits of  early 
limited resective surgery in patients in a population-
based Veszprem Province database. Results from this 
population-based inception cohort have shown that sur-
gery rates and overall exposure to steroids and biological 
agents were lower in patients with early limited resective 
surgery. In contrast, although patients with early limited 
resective surgery needed less reoperation, by Kaplan-
Meier analysis and multivariate Cox regression analysis, in 
the final propensity-score-matched model, this advantage 
was lost, and the probability of  reoperation was similar 
in patients with early limited resection and non-early 
surgery. To the best of  our knowledge, this is the first 
time that the association between early limited resective 
surgery and reoperation were studied using a propensity 
score model. 
The rates of  resective surgery vary significantly ac-
cording to previous studies with a range from 25% to 
61% in the first 5 years. An earlier review article by Wolt-
ers et al[1] reported that the probability of  first resective 
surgery was as high as 38%-96% within the first 15 years 
of  diagnosis. The overall recurrence and reoperation rates 
after first resective surgery is 50%-60% and 28%-45%, 
respectively, during the subsequent 15 years. More re-
cently, in the IBSEN Study, the cumulative probability of  
surgery was 13.6%, 27.0% and 37.9%, at 1, 5 and 10 years 
after diagnosis, respectively, while the risk of  reoperation 
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Figure 2  Need for reoperation in patients with and without early resective 
surgery (PLogrank = 0.038).
Table 5  Factors associated with the need for reoperation in 
Cox regression analysis
P  value HR 95%CI
Early surgery1
   Yes 0.04 0.42 0.19-0.95
   No Reference
Age at diagnosis
   A1 0.75 - -
   A2 Reference
Disease location 0.95
   L2 0.77 - -
   L3 0.95 - -
   L1 Reference
Disease behavior at diagnosis 0.56
   B2 0.30 - -
   B3 0.65 - -
   B1 Reference
Smoking
   Yes 0.29 - -
   No Reference
1Early resective surgery: Within the year of diagnosis.
Golovics PA et al . Early surgery in Crohn's disease
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Similarly, in a recent meta-analysis from the IOIBD 
Epidemiology Task Force, the authors reported that 
the probability of  surgery in CD decreased gradually 
between 1955 and 2003, even before the advent of  the 
biological era[3]. An association with increased and earlier 
use of  immunosuppressants was also suggested in studies 
from Wales[6] and Hungary[5]. Ramadas et al[6] found that 
the rates of  intestinal surgery decreased during the study 
period from 59% to 25% within 5 years of  diagnosis. 
There was also a significant reduction in patients hav-
ing any surgical procedure, from 60% to 35%. Likewise, 
in a previous referral center study from Hungary, early 
monotherapy with AZA or combination AZA/biological 
therapy was associated with a reduced risk for surgery. In 
earlier published studies from this cohort, the probability 
of  surgical resection was 9.8%, 18.5% and 21.3% after 1, 
3 and 5 years, respectively, in patients diagnosed between 
2002 and 2006, and a recent decrease in surgical rates (in 
patients diagnosed after 1998) was observed[12]. These 
changes were associated with increased and earlier use of  
immunosuppressants[5]. Notwithstanding, the change in 
the use of  immunosuppressants could be regarded as a 
marker of  the complex changes in patient management 
rather than an exclusive factor itself.
Additional predictors of  surgery include ileal or co-
lonic disease location, complicated disease behavior, and 
age at onset - as reported previously in Sweden[17] and 
more recently from the IBSEN cohort[16]. Similarly, ileal 
(HR = 2.35) or ileocolonic (HR = 1.79) location com-
pared to isolated colonic disease, as well as stricturing (HR 
= 4.33) or penetrating (HR = 3.44) disease at diagnosis, 
but not perianal disease, were independently associated 
with time to first surgery in a population-based cohort 
study from our research group[18]. Interestingly, we ob-
served a similar phenotype pattern associated with early 
limited resection (ileal location, P < 0.001; complicated 
behavior, P < 0.001; and age at onset, P = 0.06).
However, the risk of  surgery, as well as the disease 
course in patients with primary ileocecal CD, is some-
what different. In an earlier Swedish study, the risk of  
resective surgery in patients with primary ileocecal CD 
was 61%, 77% and 83%, after 1, 5 and 10 years of  diag-
nosis, respectively, in 907 patients[19]. Relapse rates were 
28% and 36% within 5 and 10 years of  the first resection, 
respectively. In an Italian study, clinical and surgical recur-
rence rates after 5 years were 30.6% and 49.4%, and after 
10 years they were and 3.6% and 28%, respectively[20]. In 
addition, early surgery (within 3 years of  diagnosis) was 
associated with a longer postoperative course free from 
clinical recurrence compared with late surgery, but not 
with reoperation. In the present study, despite higher 
rates of  ileal and complicated disease in patients with ear-
ly limited surgery, the overall need of  steroids (OR = 0.45, 
P < 0.001) during follow-up was lower, and there was a 
similar tendency for steroid-dependent disease course (P 
= 0.07) and need for biological agents (P = 0.09). In con-
trast, the overall use of  AZA was similar in both groups, 
which may represent an active therapeutic decision by the 
treating physician rather than a marker of  negative dis-
ease outcome. Of  note, median follow-up was similar for 
both groups (12 years). We defined early surgery as that 
performed within 1 year of  diagnosis, to avoid a poten-
tial bias due to early medical therapy. Of  note, a positive 
effect of  early aggressive medical therapy was already 
observed in patients in whom AZA was started within 18 
mo of  diagnosis, in a previous study in this cohort[5]. In 
addition, since reoperation rates may be lower in patients 
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Figure 3  Need for reoperation in Crohn's disease patients with and without early resective surgery after matching on propensity scores. A: All Crohn's dis-
ease (CD) patients (n = 54). PLogrank > 0.05; B: CD patients with ileal only disease location (n = 33). PLogrank > 0.05.
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tion, we excluded these patients from the final analysis.
Comparable data were reported by Aratari et al[9]. In 
that study, early limited surgery at diagnosis was associ-
ated with less clinical recurrence - defined as need for 
steroids and lesions documented by endoscopy or radiol-
ogy (P = 0.01), and less need for immunosuppressants (P 
= 0.05), but reoperation rates were not significantly dif-
ferent. Immunosuppressants were started in only 16.2% 
of  patients with early or late surgery, confirming that 
the medical approach reported by the authors was much 
more conservative compared to the present study. In ad-
dition, the need for immunosuppressants was interpreted 
as a negative outcome. In another Italian study, the dis-
ease course of  CD patients diagnosed during emergency 
surgery was compared to patients without emergency 
surgery[21]. The authors reported that the disease course 
was more benign in patients requiring surgery at diagno-
sis, by both univariate and multivariate analysis. Similar to 
the present study, surgery rates were significantly lower 
in patients operated on at diagnosis (in the present study 
with early limited surgery) compared to patients without 
surgery at diagnosis (in the present study without early 
limited surgery after matching on propensity scores). 
Observed surgery rates in the Italian study were 14% 
and 30% in the surgery-at-diagnosis group and 30% and 
44% in the non-early surgery group, respectively. Of  
note, this design mimics clinical trials comparing two 
treatment algorithms: (1) early limited resective surgery; 
and (2) medical therapy but no early surgery. Observed 
surgery and drug exposure rates were clearly different. 
However, a different interpretation of  our results may be 
that 40%-45% of  patients could avoid surgery despite a 
similar patient phenotype within 10 years of  diagnosis, 
while in the other group, all patients started with a limited 
operation. In addition, in the non-early surgery group, 
only 25.6% of  patients received early AZA therapy. Thus, 
their therapeutic strategy was far from optimized. More-
over, reoperation rates were also analyzed in the present 
study, which would be very difficult in a clinical trial due 
to the need for long term follow-up. These were lower in 
patients with early limited resection versus those without 
early limited resection by Kaplan-Meier (PLogrank = 0.038) 
and Cox regression (P = 0.04) analysis but the differ-
ence was lost after matching on propensity scores. Cost-
benefit was not analyzed but with the increasing exposure 
to biological agents in certain CD populations[22], these 
studies are urgently awaited.
The authors are aware of  the possible limitations of  
the present study. One such potential limitation is the 
partially retrospective nature of  the study, which may 
have led to bias in data interpretation. However, data 
were collected prospectively since 1985 and intestinal re-
section can be considered an unbiased and solid criterion, 
even retrospectively, because the indications for surgi-
cal intervention are well established. Another possible 
criticism may be the definition of  early surgery. In this 
subgroup, patients presented partly with a short history 
of  subacute or even acute symptoms. In these patients, 
the timing of  surgery was determined by the clinical 
presentation and not by the physician’s strategic deci-
sion. However, this was also the case for a proportion of  
non-early surgical patients. Patient management has also 
changed significantly with regard to surgery techniques 
(laparoscopy) and imaging (availability of  computed to-
mography and magnetic resonance imaging) that could 
have potentially affected therapeutic decision making, 
including indication for surgery. However, in the present 
study, one leading surgeon performed the majority of  the 
operations and laparoscopic surgery and stricturoplasty 
was performed only in a minority of  the cases. Similarly, 
there was only limited use of  defunctioning ileostomy 
formation in routine management of  CD during the 
follow-up period. Finally, postoperative management 
has significantly changed during the follow-up period, 
including routine endoscopy evaluation and prophylactic 
therapy; although in our analysis, we matched the groups 
for decade of  diagnosis. In addition, there is accumulat-
ing evidence that anti-TNF therapies may reduce the 
number of  operations[7,23], although this was not a univer-
sal finding[24,25]. Exposure to biological agents was limited 
in the present study, and most of  these patients received 
induction-only or intermittent infliximab therapy. In 
contrast, the strengths of  this study include the long-
term, comprehensive, validated data capture, and the use 
of  both propensity score matching and multiple Cox 
regression analysis to overcome the limitations present in 
any partly retrospective study, thereby enabling unbiased 
analysis. Moreover, a follow-up of  several years is needed 
to assess the reoperation rates, especially in patients with-
out early limited resection, which is almost impossible in 
a clinical trial.
In conclusion, early limited resective surgery was as-
sociated with a lower risk for surgery and lower overall 
exposure to steroids and biological agents in this popula-
tion-based cohort but it was not preventive for reopera-
tions after matching on propensity scores. In addition, 
the similar exposure to immunosuppressants in the two 
groups may be interpreted as an active medical deci-
sion rather than a negative disease outcome. Conversely, 
resective surgery could be avoided in 40%-45% of  CD 
patients with a similar disease phenotype without an early 
limited surgery within 10 years of  diagnosis. 
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rates were also lower, yet reoperation rates were not different in the two groups 
after matching on propensity scores
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Understanding the disease course in this subgroup of patients with CD may 
lead to more optimized patient managment and follow-up.
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